PT  - JOURNAL ARTICLE
AU  - Trinh, Nhung TH
AU  - Nordeng, Hedvig ME
AU  - Bandoli, Gretchen
AU  - Eberhard-Gran, Malin
AU  - Lupattelli, Angela
TI  - Antidepressant and mental health care utilization in pregnant women with depression and/or anxiety: an interrupted time-series analysis
AID  - 10.1101/2021.09.29.21264292
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.29.21264292
4099  - http://medrxiv.org/content/early/2021/09/29/2021.09.29.21264292.short
4100  - http://medrxiv.org/content/early/2021/09/29/2021.09.29.21264292.full
AB  - Objectives To assess mental health care utilization patterns during and after pregnancy in women with depression and/or anxiety in Norway according to antidepressant fill trajectories in pregnancy.Method We conducted a registry-linkage cohort study of pregnancies within women having outpatient visit for depression and/or anxiety and antidepressant fills in the six months prior to pregnancy identified from four national registries of Norway (2009-2018). Number of consultations for depression/anxiety per 100 pregnancies as proxy of mental health care utilization were modelled using interrupted time-series analysis with first month into pregnancy and first month after delivery as interruption points. We investigated the time window including six months prior to pregnancy, eight months into pregnancy and one year postpartum. Antidepressant fill trajectories in the corresponding time window were identified using longitudinal k-means trajectory modelling.Results The cohort included 8,460 pregnancies within 8,062 women with depression/anxiety. We observed reduced mental health care utilization when pregnant women entered the course of pregnancy (negative slopes during pregnancy for all psychiatric specialists and psychologists). The declines were observed for all antidepressant fill trajectories (i.e., discontinuers and continuers) except interrupters (i.e., discontinued then resumed treatment). We found increased mental health care utilization in the postpartum year, notably in interrupters (positive slopes in consultation rates with specialists of outpatient clinics and public-contracted psychiatrists)..Conclusions Pregnancy was associated with reduced mental health care utilization regardless of whether antidepressant treatment was maintained during pregnancy or not. Increases in mental health care utilization were observed in the postpartum year, especially in interrupters.SIGNIFICANT OUTCOMES- Pregnancy is associated with reduced mental health care utilization in pregnant women with depression and/or anxiety in Norway.- The reduction in mental health care utilization during pregnancy was observed for all antidepressant fill trajectories, except for interrupters.- Increased in mental health care utilization in the postpartum year was observed, especially among those who discontinued then resumed antidepressant treatment.LIMITATIONS- The reasons for antidepressant discontinuation, and whether that was due to symptom remission were not assessed.- It was not possible to determine whether reduced mental health care utilization was associated with undertreatment during pregnancy.- It was not possible to measure directly the use of psychosocial interventions and psychotherapy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNhung Trinh and Angela Lupattelli are supported by the Norwegian Research Council (grant no. 288696). Hedvig Nordeng is supported by a European Research Council Starting Grant DrugsInPregnancy (grant number 639377). No financial relationships with any organizations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work. The funders had no role in the design and conduct of the study; the analysis and interpretation of the data; preparation; the review or approval of the manuscript. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Regional Committee for Research Ethics in South Eastern Norway (approval number 2018/140/REK Soer Oest) and by the Data Protection Officer at the University of Oslo (approval number 58033). Data were handled in accordance with the General Data Protection Regulation.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data in this project were delivered by the registry holders to the researchers as pseudonymized data files. Data are available upon request to the registry holders, provided legal and ethical approvals.